Drugs Made In America Acquisition Corp是一家总部位于美国的公司,从事行业运营。公司总部位于佛罗里达州劳德代尔堡。该公司于2025年1月28日首次公开募股(IPO)。Drugs Made In America Acquisition Corp是一家空白支票公司。该公司注册为免税公司,旨在与一个或多个企业进行合并、股份交换、资产收购、股份购买、资本重组、重组或其他类似业务合并。尽管该公司计划专注于在制药行业中寻找业务合并目标,但其寻找潜在目标企业的努力不限定于特定行业或地理区域。
DMAAU stock price ended at $10.55 on 星期四, after rising 0.00%
On the latest trading day Jan 29, 2026, the stock price of DMAAU rose by 0.00%, climbing from $10.55 to $10.55. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $10.55 and a high of $10.55. Notably, trading volume dropped by 322 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 608 shares were traded, equating to a market value of approximately $353.6M.